Nano Research · 2016 · 117 citations · 36 references
Life SciencesBiochemistryBiotechnologyBiocatalysisDementiaEnzymologyAlzheimer DiseaseBiocatalyst EngineeringDementia TreatmentEnzyme DesignEnzyme FunctionNeurodegenerative DiseasesAlzheimer Disease DementiaAmyloid Beta AggregationEnzyme-responsive NanomaterialsPharmacological Treatment Of DementiaTherapeutic Enzyme EngineeringTherapeutic Targeting Of Amyloid
Proteolytic degradation of amyloid-β (Aβ) aggregates and clearance of Aβ-induced reactive oxygen species (ROS) have received significant attention for the treatment of Alzheimer’s disease (AD). However, it is difficult, and often unfeasible, to directly upregulate or transport intracellular native enzymes. More importantly, penetration of the blood-brain barrier (BBB) has presented a major impediment. Herein, we report on the rational design of a polyoxometalatebased nanozyme with both protease-like activity for depleting Aβ aggregates, and superoxide dismutase (SOD)-like activity for scavenging Aβ-mediated ROS. Furthermore, this nanozyme acts as a metal chelator to remove Cu from Cu-induced Aβ oligomers. More intriguingly, the nanozyme can cross the BBB and exhibits low toxicity. This work provides new insights into the design and synthesis of inorganic nanozymes as multifunctional therapeutic agents in the treatment of AD.
36
A new mixing of Hartree–Fock and local density-functional theories
Axel D. Becke · The Journal of Chemical Physics · 1993 · 16.4K citations
Natural Sciences, Chemistry, Physics +11
Density-Functional Theory for Time-Dependent Systems
Erich Runge, E. K. U. Gross · Physical Review Letters · 1984 · 8.8K citations
Intrinsic peroxidase-like activity of ferromagnetic nanoparticles
Lizeng Gao, Jie Zhuang, Leng Nie et al. · Nature Nanotechnology · 2007 · 7.3K citations